3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain

被引:16
|
作者
Yasojima, K [1 ]
McGeer, EG [1 ]
McGeer, PL [1 ]
机构
[1] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada
关键词
ApoE; cholesterol synthesis; heart; kidney; liver; spleen; statins;
D O I
10.1097/00001756-200109170-00036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Statins are widely used pharmaceutical agents which lower plasma cholesterol by inhibiting the rate controlling enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase. One epidemiological study suggests that statin therapy may provide protection against Alzheimer disease (AD). The aim of the present study was to determine the relative expression of HMG-CoA reductase nnRNAs in various areas of brain as well as in peripheral organs and to compare values in AD and control cases. High levels of the mRNA were found in all areas of brain but no obvious differences were found between AD and controls. We conclude that brain has a robust capacity to synthesize cholesterol which appears to be unaffected by AD pathology. NeuroReport 12:2935-2938 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:2935 / 2938
页数:4
相关论文
共 50 条
  • [31] Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
    Simard, C
    Poirier, P
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (02) : 141 - 144
  • [32] Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
    Hajri, T
    Chanussot, F
    Ferezou, J
    Riottot, M
    Lafont, H
    Laruelle, C
    Lutton, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (01) : 65 - 71
  • [33] The influence of hydrophilic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (pravastatin) on gelatinase activity in vitro
    Kurzepa, Jacek
    Stryjecka-Zimmer, Marta
    Szczepanska-Szerej, Anna
    Kurzepa, Joanna
    PHARMACEUTICAL BIOLOGY, 2009, 47 (10) : 924 - 926
  • [34] Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer
    Wei, Tzu-Tang
    Lin, Yi-Ting
    Chen, Wen-Shu
    Luo, Ping
    Lin, Yu-Chin
    Shun, Chia-Tung
    Lin, Yi-Hsin
    Chen, Jhih-Bin
    Chen, Nai-Wei
    Fang, Jim-Min
    Wu, Ming-Shiang
    Yang, Kai-Chien
    Chang, Li-Chun
    Tai, Kang-Yu
    Liang, Jin-Tung
    Chen, Ching-Chow
    EBIOMEDICINE, 2016, 10 : 124 - 136
  • [35] POTENTIAL ROLE FOR PHOSPHOLIPIDS IN THE REGULATION OF "3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE IN CULTURED C-6 GLIAL-CELLS - EFFECTS OF N,N-DIMETHYLETHANOLAMINE
    FINKEL, RS
    VOLPE, JJ
    BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 572 (03) : 461 - 471
  • [36] Liver-Specific Deletion of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Causes Hepatic Steatosis and Death
    Nagashima, Shuichi
    Yagyu, Hiroaki
    Ohashi, Ken
    Tazoe, Fumiko
    Takahashi, Manabu
    Ohshiro, Taichi
    Bayasgalan, Tumenbayar
    Okada, Kenta
    Sekiya, Motohiro
    Osuga, Jun-ichi
    Ishibashi, Shun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (08) : 1824 - U277
  • [37] 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the progression of renal dysfunction in Japanese hypertensive patients
    Kuwabara, Masanori
    Kubo, Toru
    Bando, Kanji
    Hirakawa, Yoko
    Kitaoka, Hiroaki
    Nishinaga, Masanori
    Doi, Yoshinori L.
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2010, 10 (03) : 219 - 224
  • [38] Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells - A mechanism for development of atherosclerosis?
    Li, H
    Lewis, A
    Brodsky, S
    Rieger, R
    Iden, C
    Goligorsky, MS
    CIRCULATION, 2002, 105 (09) : 1037 - 1043
  • [39] Association of Common and Rare Genetic Variation in the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk
    Ghouse, Jonas
    Ahlberg, Gustav
    Skov, Anne Guldhammer
    Bundgaard, Henning
    Olesen, Morten S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (12):
  • [40] Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
    Dechend, R
    Fiebeler, A
    Park, JK
    Muller, DN
    Theuer, J
    Mervaala, E
    Bieringer, M
    Gulba, D
    Dietz, R
    Luft, FC
    Haller, H
    CIRCULATION, 2001, 104 (05) : 576 - 581